{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:51:22Z","timestamp":1789671082482,"version":"4.0.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":3256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R21AI111152"],"award-info":[{"award-number":["R21AI111152"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Ministry of Science & Technology","award":["201200007673"],"award-info":[{"award-number":["201200007673"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.micinf.2014.12.006","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T21:08:53Z","timestamp":1419023333000},"page":"123-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Advancements in the development of subunit influenza vaccines"],"prefix":"10.1016","volume":"17","author":[{"given":"Naru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2014.12.006_bib1","series-title":"Topley and Wilson's microbiology and microbial infections","article-title":"Orthomyxoviruses: influenza","author":"Cox","year":"2010"},{"key":"10.1016\/j.micinf.2014.12.006_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7774\/cevr.2014.3.2.117","article-title":"Evolutionary dynamics of highly pathogenic avian influenza A\/H5N1 HA clades and vaccine implementation in Vietnam","volume":"3","author":"Le","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1090350","article-title":"Are we ready for pandemic influenza?","volume":"302","author":"Webby","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.micinf.2014.12.006_bib4","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2014.12.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.9716","article-title":"Role of hemagglutinin cleavage for the pathogenicity of influenza virus","volume":"258","author":"Steinhauer","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib6","first-page":"153","article-title":"Influenza A: understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale J Bio Med"},{"key":"10.1016\/j.micinf.2014.12.006_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2004.08.012","article-title":"Assembly and budding of influenza virus","volume":"106","author":"Nayak","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid1204.051020","article-title":"Prospects for universal influenza virus vaccine","volume":"12","author":"Gerhard","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/emboj\/17.1.288","article-title":"The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins","volume":"17","author":"O'Neill","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.micinf.2014.12.006_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-3527(05)65004-X","article-title":"Influenza virus virulence and its molecular determinants","volume":"65","author":"Noah","year":"2005","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/nar\/gkg253","article-title":"Activation of influenza virus RNA polymerase by the 5\u2032 and 3\u2032 terminal duplex of genomic RNA","volume":"31","author":"Lee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0264-410X(03)00069-0","article-title":"The epidemiology and clinical impact of pandemic influenza","volume":"21","author":"Nguyen-Van-Tam","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.96.4.1651","article-title":"Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene","volume":"96","author":"Reid","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2014.12.006_bib15","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1073\/pnas.100140097","article-title":"Characterization of the 1918 \u201cSpanish\u201d influenza virus neuraminidase gene","volume":"97","author":"Reid","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2014.12.006_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1637\/0005-2086-47.s3.921","article-title":"Relationship of pre-1918 avian influenza HA and NP sequences to subsequent avian influenza strains","volume":"47","author":"Reid","year":"2003","journal-title":"Avian Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0042-6822(78)90153-8","article-title":"On the origin of the\u00a0human influenza virus subtypes H2N2 and H3N2","volume":"87","author":"Scholtissek","year":"1978","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib18","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/jvi.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/00333549101250S305","article-title":"Influenza: the once and future pandemic","volume":"125","author":"Taubenberger","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/j.micinf.2014.12.006_bib20","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/514171","article-title":"Perspectives on pandemics: a research agenda","volume":"176","author":"Kilbourne","year":"1997","journal-title":"J Infec Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2014.12.006_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.micinf.2014.12.006_bib23","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/JVI.02565-08","article-title":"Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses","volume":"83","author":"Dunham","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMp0904819","article-title":"The persistent legacy of the 1918 influenza virus","volume":"361","author":"Morens","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2014.12.006_bib25","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1128\/JVI.73.10.8851-8856.1999","article-title":"Genetic reassortment of avian, swine, and human influenza A viruses in American pigs","volume":"73","author":"Zhou","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-1702(02)00027-8","article-title":"The emergence of novel swine influenza viruses in North America","volume":"85","author":"Olsen","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib27","first-page":"75","article-title":"Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man","volume":"59","author":"Pensaert","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.micinf.2014.12.006_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.20506\/rst.19.2.1230","article-title":"Highly pathogenic avian influenza","volume":"19","author":"Swayne","year":"2000","journal-title":"Revue Sci Tech (International Office of Epizootics)"},{"key":"10.1016\/j.micinf.2014.12.006_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/viro.1999.9820","article-title":"Genetic characterization of the pathogenic influenza A\/Goose\/Guangdong\/1\/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong","volume":"261","author":"Xu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2307\/1592975","article-title":"Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza","author":"Swayne","year":"2001","journal-title":"Avian Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2011.07.004","article-title":"Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010","volume":"92","author":"Meijer","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3201\/eid1704.101467","article-title":"Drug-resistant pandemic (H1N1) 2009, South Korea","volume":"17","author":"Shin","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib33","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","article-title":"Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses","volume":"69","author":"Hurt","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.micinf.2014.12.006_bib34","first-page":"507","article-title":"Isolation and properties of amantadine-resistant variants of influenza A virus","volume":"16","author":"Lavrov","year":"1972","journal-title":"Acta Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib35","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1155\/2010\/710149","article-title":"Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008)","volume":"21","author":"Pabbaraju","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.micinf.2014.12.006_bib36","first-page":"165","article-title":"Designing vaccines for pandemic influenza","volume":"333","author":"Horimoto","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib37","article-title":"Live attenuated and inactivated influenza vaccines in children","author":"Ilyushina","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib38","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1016\/j.vaccine.2014.07.097","article-title":"Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity","volume":"32","author":"Ambrose","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.09.048","article-title":"Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus","author":"Peeters","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib40","first-page":"177","article-title":"Attenuated influenza virus vaccines with\u00a0modified NS1 proteins","volume":"333","author":"Richt","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib41","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1016\/j.vaccine.2014.07.078","article-title":"Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans","volume":"32","author":"Overton","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib42","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1128\/JVI.02490-12","article-title":"Influenza viruses with rearranged genomes as live-attenuated vaccines","volume":"87","author":"Pena","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib43","first-page":"9","article-title":"Regulatory philosophy and acceptability of cells for the production of biologicals","volume":"75","author":"Petricciani","year":"1991","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.micinf.2014.12.006_bib44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","article-title":"Development of a mammalian cell (Vero) derived candidate influenza virus vaccine","volume":"16","author":"Kistner","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00705-013-1878-1","article-title":"Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice","volume":"159","author":"Chen","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/vim.2010.0056","article-title":"Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus","volume":"24","author":"Xu","year":"2011","journal-title":"Viral Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib47","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/jvi.71.5.3391-3396.1997","article-title":"Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin","volume":"71","author":"Kodihalli","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib48","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.73.3.2094-2098.1999","article-title":"DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice","volume":"73","author":"Kodihalli","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib49","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2011.05.062","article-title":"Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e","volume":"29","author":"Park","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib51","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.vaccine.2013.02.061","article-title":"A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A (H1N1) pdm09 virus infection","volume":"31","author":"Bragstad","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BA20030011","article-title":"Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA","volume":"37","author":"Shamlou","year":"2003","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.micinf.2014.12.006_bib53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0141-0229(03)00205-9","article-title":"Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification","volume":"33","author":"Prather","year":"2003","journal-title":"Enzyme Micro Technol"},{"key":"10.1016\/j.micinf.2014.12.006_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1021\/bp050190n","article-title":"Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic","volume":"21","author":"Hoare","year":"2005","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.micinf.2014.12.006_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-8518-7-3","article-title":"Prospects for control of emerging infectious diseases with\u00a0plasmid DNA vaccines","volume":"7","author":"Moss","year":"2009","journal-title":"J Immune Based Ther Vaccines"},{"key":"10.1016\/j.micinf.2014.12.006_bib56","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/10430340050083243","article-title":"Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease","volume":"11","author":"Shen","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.micinf.2014.12.006_bib57","doi-asserted-by":"crossref","first-page":"B281","DOI":"10.1093\/gerona\/53A.4.B281","article-title":"Immunogenicity and efficacy of a DNA vaccine in aged mice","volume":"53","author":"Klinman","year":"1998","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.micinf.2014.12.006_bib58","doi-asserted-by":"crossref","first-page":"e75460","DOI":"10.1371\/journal.pone.0075460","article-title":"Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection","volume":"8","author":"Kim","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib59","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1128\/JVI.00120-13","article-title":"Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib60","doi-asserted-by":"crossref","first-page":"e62496","DOI":"10.1371\/journal.pone.0062496","article-title":"Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness","volume":"8","author":"Vemula","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mi.2014.59","article-title":"Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes","volume":"8","author":"Fan","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib62","first-page":"531","article-title":"Virus-like particles as vaccine","volume":"61","author":"Chroboczek","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.micinf.2014.12.006_bib63","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1128\/JVI.74.18.8709-8719.2000","article-title":"Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein","volume":"74","author":"Ali","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib64","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/abbs\/36.8.548","article-title":"Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle","volume":"36","author":"Zheng","year":"2004","journal-title":"Acta Biochim Biophy Sin (Shanghai)"},{"key":"10.1016\/j.micinf.2014.12.006_bib65","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/jcm.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.micinf.2014.12.006_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.antiviral.2010.02.315","article-title":"Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice","volume":"86","author":"Prabakaran","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4161\/hv.27567","article-title":"Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge","volume":"10","author":"Mallajosyula","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micinf.2014.12.006_bib68","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/jvi.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000319440","article-title":"Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens","volume":"54","author":"Zhang","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.micinf.2014.12.006_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1743-422X-10-227","article-title":"An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge","volume":"10","author":"Ma","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.12.006_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1743-422X-7-151","article-title":"An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.12.006_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.12.006_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2012.04.015","article-title":"In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran","volume":"430","author":"Ebrahimi","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib75","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2012.11.072","article-title":"Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice","volume":"31","author":"Alvarez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib76","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2010.08.049","article-title":"Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant","volume":"28","author":"Zhao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2014.12.006_bib78","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.180.3.1758","article-title":"Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus","volume":"180","author":"Roti","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib79","doi-asserted-by":"crossref","first-page":"e61775","DOI":"10.1371\/journal.pone.0061775","article-title":"Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence","volume":"8","author":"MacLeod","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib80","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1128\/JVI.79.17.11239-11246.2005","article-title":"Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes","volume":"79","author":"Berkhoff","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib81","first-page":"145","article-title":"Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant","volume":"36","author":"Cargnelutti","year":"2013","journal-title":"New Microbiol"},{"key":"10.1016\/j.micinf.2014.12.006_bib82","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.vaccine.2013.10.017","article-title":"Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1) pdm09 virus: a Phase 1 dose-escalation study in healthy adults","volume":"32","author":"Cummings","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib83","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1016\/j.vaccine.2013.09.009","article-title":"A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB\/c mice from lethal challenge","volume":"31","author":"Liu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib84","doi-asserted-by":"crossref","first-page":"e92822","DOI":"10.1371\/journal.pone.0092822","article-title":"Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib85","doi-asserted-by":"crossref","first-page":"e16555","DOI":"10.1371\/journal.pone.0016555","article-title":"A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses","volume":"6","author":"Du","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib86","doi-asserted-by":"crossref","first-page":"e53568","DOI":"10.1371\/journal.pone.0053568","article-title":"A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection","volume":"8","author":"Du","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib87","doi-asserted-by":"crossref","first-page":"546274","DOI":"10.1155\/2014\/546274","article-title":"Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development","volume":"2014","author":"Khanna","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.micinf.2014.12.006_bib88","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2014.12.006_bib89","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2014.12.006_bib90","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1016\/j.vaccine.2010.09.019","article-title":"Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant","volume":"28","author":"Sui","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib91","first-page":"227","article-title":"Influenza neuraminidase as a vaccine antigen","volume":"333","author":"Sylte","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.micinf.2014.12.006_bib92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2014.02.011","article-title":"Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus","volume":"454","author":"Lu","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib94","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"Rockman","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.12.006_bib95","doi-asserted-by":"crossref","first-page":"e52135","DOI":"10.1371\/journal.pone.0052135","article-title":"Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib96","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.virol.2008.08.002","article-title":"Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant","volume":"380","author":"Prabakaran","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2014.12.006_bib97","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1016\/j.vaccine.2014.08.068","article-title":"Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59\u00ae-adjuvanted influenza vaccine in infants and young children","volume":"32","author":"Nolan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4110\/in.2012.12.6.261","article-title":"Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus","volume":"12","author":"Park","year":"2012","journal-title":"Immune Netw"},{"key":"10.1016\/j.micinf.2014.12.006_bib100","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","article-title":"Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses","volume":"32","author":"Gallorini","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib101","doi-asserted-by":"crossref","first-page":"e69649","DOI":"10.1371\/journal.pone.0069649","article-title":"Evaluation of mucosal and systemic immune responses elicited by GPI-0100-adjuvanted influenza vaccine delivered by different immunization strategies","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1743-422X-9-286","article-title":"Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein","volume":"9","author":"Luo","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.12.006_bib103","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.micinf.2014.12.006_bib104","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1743-422X-10-104","article-title":"Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice","volume":"10","author":"Kim","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.12.006_bib105","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib106","doi-asserted-by":"crossref","first-page":"e6509","DOI":"10.1371\/journal.pone.0006509","article-title":"Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses","volume":"4","author":"Nayak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.12.006_bib107","first-page":"117","article-title":"Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice","volume":"78","author":"Wu","year":"2014","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.micinf.2014.12.006_bib108","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.2014.12609","article-title":"Immunogenicity of avian influenza A\/Anhui\/01\/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Belshe","year":"2014","journal-title":"J Am Mes Assoc"},{"key":"10.1016\/j.micinf.2014.12.006_bib109","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2014.12.006_bib110","article-title":"AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2\/3 randomized, placebo-controlled, observer-blinded trial","author":"Kosalaraksa","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib111","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.micinf.2014.12.006_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib113","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S1473-3099(14)70963-6","article-title":"Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1\/2a clinical trial","volume":"14","author":"Kreijtz","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib114","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/v4113227","volume":"4","author":"Chichester","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2014.12.006_bib115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14712598.2013.748030","article-title":"Aflunov\u00ae: a vaccine tailored for pre-pandemic and pandemic approaches against influenza","volume":"13","author":"Del Giudice","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.micinf.2014.12.006_bib116","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib117","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/erv.11.170","article-title":"Aflunov(\u00ae): a prepandemic influenza vaccine","volume":"11","author":"Gasparini","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2014.12.006_bib118","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2014.07.074","article-title":"Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process","volume":"32","author":"Buckland","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib119","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/jiq093","article-title":"Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant","volume":"203","author":"Belshe","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2014.12.006_bib120","article-title":"Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial","author":"Langley","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.12.006_bib121","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2014.07.011","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized phase I clinical trial in healthy Asian volunteers","volume":"32","author":"Low","year":"2014","journal-title":"Vaccine"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791400327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791400327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:35:54Z","timestamp":1761143754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645791400327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S128645791400327X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2014.12.006","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in the development of subunit influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institut Pasteur. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}